688739 成大生物
已收盘 02-05 15:00:01
资讯
新帖
简况
成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%
证券之星 · 02-05 22:26
成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%
成大生物拟与控股股东及其关联方共同设立规模最高10亿元产业投资基金
美股速递 · 02-05 16:27
成大生物拟与控股股东及其关联方共同设立规模最高10亿元产业投资基金
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,2月2日股价下跌2.26%
证券之星 · 02-02
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,2月2日股价下跌2.26%
每周股票复盘:成大生物(688739)2025年净利预降59%
证券之星 · 02-01
每周股票复盘:成大生物(688739)2025年净利预降59%
成大生物终止hib疫苗研发项目,将减少2025年度利润总额超8000万元
每日经济新闻 · 01-27
成大生物终止hib疫苗研发项目,将减少2025年度利润总额超8000万元
成大生物(688739)披露2025年年度业绩预告,1月26日股价上涨2.09%
证券之星 · 01-26
成大生物(688739)披露2025年年度业绩预告,1月26日股价上涨2.09%
成大生物(688739.SH)发预减,预计2025年归母净利润1.23亿元至1.39亿元,同比减少59.34%至63.98%
智通财经 · 01-26
成大生物(688739.SH)发预减,预计2025年归母净利润1.23亿元至1.39亿元,同比减少59.34%至63.98%
成大生物最新公告:拟与控股股东等共同设立生物医药产业投资基金
证券之星 · 01-26
成大生物最新公告:拟与控股股东等共同设立生物医药产业投资基金
每周股票复盘:成大生物(688739)子公司募资专户设立
证券之星 · 01-11
每周股票复盘:成大生物(688739)子公司募资专户设立
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,1月6日股价上涨0.58%
证券之星 · 01-06
成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,1月6日股价上涨0.58%
每周股票复盘:成大生物(688739)部分募投项目延期并调整结构
证券之星 · 01-02
每周股票复盘:成大生物(688739)部分募投项目延期并调整结构
成大生物(688739)披露部分募投项目延期及调整内部投资结构公告,12月31日股价下跌0.23%
证券之星 · 2025-12-31
成大生物(688739)披露部分募投项目延期及调整内部投资结构公告,12月31日股价下跌0.23%
每周股票复盘:成大生物(688739)拟增资1亿元实施疫苗项目
证券之星 · 2025-12-28
每周股票复盘:成大生物(688739)拟增资1亿元实施疫苗项目
成大生物一月内终止6个疫苗项目,核心产品市占率与价格双降,业绩连跌如何破局?
新浪证券 · 2025-12-25
成大生物一月内终止6个疫苗项目,核心产品市占率与价格双降,业绩连跌如何破局?
成大生物(688739)披露部分募投项目延期及调整计划,12月24日股价上涨0.58%
证券之星 · 2025-12-24
成大生物(688739)披露部分募投项目延期及调整计划,12月24日股价上涨0.58%
成大生物(688739)披露部分募投项目内部投资结构调整公告,12月19日股价上涨0.34%
证券之星 · 2025-12-19
成大生物(688739)披露部分募投项目内部投资结构调整公告,12月19日股价上涨0.34%
1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上
每日经济新闻 · 2025-12-19
1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上
成大生物(688739)披露关于2025年第二次临时股东会增加临时提案暨延期召开的公告,12月18日股价上涨0.38%
证券之星 · 2025-12-18
成大生物(688739)披露关于2025年第二次临时股东会增加临时提案暨延期召开的公告,12月18日股价上涨0.38%
成大生物最新公告:调整部分募集资金投资项目内部投资结构
证券之星 · 2025-12-18
成大生物最新公告:调整部分募集资金投资项目内部投资结构
成大生物:拟续聘致同会计师事务所为2025年度审计机构
证券日报网 · 2025-12-07
成大生物:拟续聘致同会计师事务所为2025年度审计机构
加载更多
公司概况
公司名称:
辽宁成大生物股份有限公司
所属行业:
医药制造业
上市日期:
2021-10-28
主营业务:
辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产与销售。公司的主要产品是人用狂犬病疫苗和人用乙脑灭活疫苗。
发行价格:
110.00
{"stockData":{"symbol":"688739","market":"SH","secType":"STK","nameCN":"成大生物","latestPrice":25.89,"timestamp":1770274801000,"preClose":25.79,"halted":0,"volume":2291406,"delay":0,"changeRate":0.0039,"floatShares":416000000,"shares":416000000,"eps":0.4273,"marketStatus":"已收盘","change":0.1,"latestTime":"02-05 15:00:01","open":25.8,"high":26.07,"low":25.71,"amount":59433700,"amplitude":0.014,"askPrice":25.91,"askSize":20,"bidPrice":25.89,"bidSize":8,"shortable":0,"etf":0,"ttmEps":0.4273,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":5,"adr":0,"adjPreClose":25.79,"symbolType":"stock_kcb","openAndCloseTimeList":[[1770255000000,1770262200000],[1770267600000,1770274800000]],"highLimit":28.37,"lowLimit":23.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":416450000,"isCdr":false,"pbRate":1.15,"roa":"--","peRate":60.58975,"roe":"1.74%","epsLYR":0.83,"committee":0.221135,"marketValue":10782000000,"turnoverRate":0.0055,"status":0,"afterMarket":{"amount":0,"volume":0,"close":25.89,"buyVolume":0,"sellVolume":0,"time":1770276837558,"indexStatus":"已收盘 02-05 15:30:00","preClose":25.79},"floatMarketCap":10782000000},"requestUrl":"/m/hq/s/688739","defaultTab":"news","newsList":[{"id":"2609309248","title":"成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309248","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309248?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:26","pubTimestamp":1770301580,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘,成大生物报收于25.89元,较前一交易日上涨0.39%,最新总市值为107.82亿元。该股当日开盘25.8元,最高26.07元,最低25.71元,成交额达5943.37万元,换手率为0.55%。近日,辽宁成大生物股份有限公司披露《2026年第一次临时股东会会议资料》。公告显示,公司拟与控股股东辽宁成大及其全资子公司共同发起设立成大生物医药产业投资基金,基金设立规模为50,200万元,公司作为有限合伙人认缴出资4亿元。本次事项构成关联交易,需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","688739","BK0239","161726"],"gpt_icon":0},{"id":"1117273287","title":"成大生物拟与控股股东及其关联方共同设立规模最高10亿元产业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=1117273287","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117273287?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:27","pubTimestamp":1770280044,"startTime":"0","endTime":"0","summary":"成大生物(688739)发布公告称,公司计划与控股股东及其关联方合作,共同设立一支总规模不超过10亿元人民币的产业投资基金。该基金将重点投向生物医药、医疗器械等与大健康产业相关的优质项目,旨在通过资本运作加速产业链布局,提升公司长期核心竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2608857969","title":"成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,2月2日股价下跌2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608857969","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608857969?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:56","pubTimestamp":1770026182,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘,成大生物报收于25.56元,较前一交易日下跌2.26%,最新总市值为106.44亿元。近日,辽宁成大生物股份有限公司发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示,公司于2025年6月19日召开董事会,审议通过以集中竞价交易方式回购公司股份的方案,回购期限为2025年6月19日至2026年6月18日,预计回购金额为1,000万元至2,000万元,用于员工持股计划或股权激励,回购价格不超过38.00元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200026721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2608270077","title":"每周股票复盘:成大生物(688739)2025年净利预降59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608270077","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608270077?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:27","pubTimestamp":1769887630,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,成大生物报收于26.15元,较上周的26.81元下跌2.46%。本周关注点来自业绩披露要点:成大生物预计2025年归母净利润同比下降59.34%至63.98%。来自公司公告汇总:公司拟终止hib疫苗研发项目,计提减值准备8,067万元。公司公告汇总辽宁成大生物股份有限公司预计2025年年度归母净利润为12,347.00万元至13,939.00万元,同比减少59.34%至63.98%;扣非净利润为3,185.00万元至4,777.00万元,同比减少85.25%至90.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2606498222","title":"成大生物终止hib疫苗研发项目,将减少2025年度利润总额超8000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606498222","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606498222?lang=zh_cn&edition=full","pubTime":"2026-01-27 07:43","pubTimestamp":1769470980,"startTime":"0","endTime":"0","summary":" 1月26日,成大生物公告称,公司决定终止“b型流感嗜血杆菌结合疫苗”研发项目。公司拟对该项目研发资本化金额8067万元全额计提资产减值准备,预计将导致公司2025年度利润总额减少8067万元。 公司表示,此次计提系对已终止项目资产的合规会计处理,不影响正常生产经营。 截至公告披露日,hib疫苗项目累计投入1.61亿元,其中费用化金额8059万元,资本化金额8067万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-01-27/doc-inhisvwk5856226.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-01-27/doc-inhisvwk5856226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159646","BK0239","688739"],"gpt_icon":0},{"id":"2606467182","title":"成大生物(688739)披露2025年年度业绩预告,1月26日股价上涨2.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606467182","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606467182?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:28","pubTimestamp":1769437698,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘,成大生物报收于27.37元,较前一交易日上涨2.09%,最新总市值为113.98亿元。该股当日开盘26.87元,最高27.59元,最低26.71元,成交额达1.76亿元,换手率为1.56%。近日,辽宁成大生物股份有限公司发布2025年年度业绩预告。公告显示,公司预计2025年年度实现归属于母公司所有者的净利润为12,347.00万元至13,939.00万元,同比减少59.34%至63.98%;扣除非经常性损益后的净利润为3,185.00万元至4,777.00万元,同比减少85.25%至90.16%。本次业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600035926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2606174352","title":"成大生物(688739.SH)发预减,预计2025年归母净利润1.23亿元至1.39亿元,同比减少59.34%至63.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606174352","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606174352?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:14","pubTimestamp":1769429688,"startTime":"0","endTime":"0","summary":"智通财经APP讯,成大生物(688739.SH)发布公告,公司预计2025年年度实现归属于母公司所有者的净利润为1.23亿元至1.39亿元,与上年同期(法定披露数据)相比,将减少20,343.16万元至21,935.16万元,同比减少59.34%至63.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"成大生物(688739.SH)发预减,预计2025年归母净利润1.23亿元至1.39亿元,同比减少59.34%至63.98%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688739"],"gpt_icon":0},{"id":"2606211320","title":"成大生物最新公告:拟与控股股东等共同设立生物医药产业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2606211320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606211320?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:38","pubTimestamp":1769423898,"startTime":"0","endTime":"0","summary":"成大生物(688739.SH)公告称,公司拟与控股股东辽宁成大及其全资子公司成大沿海、公司全资子公司深圳成大生物共同投资设立成大生物医药产业投资基金(有限合伙),基金总规模不超过100,000万元。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600026057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0239","688739","399441"],"gpt_icon":0},{"id":"2602536463","title":"每周股票复盘:成大生物(688739)子公司募资专户设立","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536463","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536463?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:06","pubTimestamp":1768075571,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,成大生物报收于26.6元,较上周的25.76元上涨3.26%。本周关注点公司公告汇总:子公司成大生物(本溪)开立1亿元募集资金专户,用于流感疫苗项目。本溪子公司已在上海浦东发展银行股份有限公司沈阳分行开立募集资金专户,账号为71010078801200005590,截至2026年1月5日余额为0万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2601932418","title":"成大生物(688739)披露以集中竞价交易方式回购公司股份的进展公告,1月6日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601932418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601932418?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:50","pubTimestamp":1767693030,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,成大生物报收于26.21元,较前一交易日上涨0.58%,最新总市值为109.15亿元。该股当日开盘26.16元,最高26.24元,最低26.0元,成交额达4943.09万元,换手率为0.45%。近日,辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。公司表示,本次回购进展符合相关法律法规及公司内部规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600030546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2600039119","title":"每周股票复盘:成大生物(688739)部分募投项目延期并调整结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2600039119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600039119?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:14","pubTimestamp":1767298452,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,成大生物报收于26.17元,较上周的26.24元下跌0.27%。本次股东会于2025年12月31日以现场和网络投票方式召开,审议通过了关于部分募投项目延期、调整内部投资结构并向全资子公司增资、部分募集资金投资项目内部投资结构调整及续聘会计师事务所的议案。表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2595244777","title":"成大生物(688739)披露部分募投项目延期及调整内部投资结构公告,12月31日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595244777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595244777?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:32","pubTimestamp":1767191539,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,成大生物报收于25.76元,较前一交易日下跌0.23%,最新总市值为107.28亿元。该股当日开盘25.82元,最高25.88元,最低25.72元,成交额达2506.38万元,换手率为0.23%。本次股东会于2025年12月31日以现场和网络投票方式召开,审议通过了关于部分募投项目延期、调整内部投资结构并向全资子公司增资、部分募集资金投资项目内部投资结构调整及续聘会计师事务所的议案。表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100045005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2594247496","title":"每周股票复盘:成大生物(688739)拟增资1亿元实施疫苗项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247496","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247496?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:32","pubTimestamp":1766871136,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,成大生物报收于26.17元,较上周的26.24元下跌0.27%。本周,成大生物12月26日盘中最高价报26.29元。本周关注点公司公告汇总:成大生物拟向全资子公司增资10,000万元用于实施“流感病毒裂解疫苗(高剂量)”项目。公司还拟续聘致同会计师事务所为2025年度审计机构,预计审计费用合计不超过70万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","688739","BK0239"],"gpt_icon":0},{"id":"2594623524","title":"成大生物一月内终止6个疫苗项目,核心产品市占率与价格双降,业绩连跌如何破局?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594623524","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594623524?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:36","pubTimestamp":1766655360,"startTime":"0","endTime":"0","summary":"近日,辽宁成大生物股份有限公司宣布终止“b型流感嗜血杆菌结合疫苗”的研发。这已是本月内该公司第6个宣告终止的疫苗子项目。在国产疫苗市场竞争日趋激烈的背景下,这家曾经凭借人用狂犬病疫苗占据市场主导地位的企业,正面临核心产品收入萎缩、新研发管线收缩、业绩连续三年下滑的多重挑战。但截至2025年10月31日,该项目已投入募集资金4.82亿元,近期却密集终止包括Hib疫苗在内的6个子项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-12-25/doc-inhczhsf8850686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688739","BK0239","159646"],"gpt_icon":0},{"id":"2593408232","title":"成大生物(688739)披露部分募投项目延期及调整计划,12月24日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593408232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593408232?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:00","pubTimestamp":1766588445,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘,成大生物报收于26.06元,较前一交易日上涨0.58%,最新总市值为108.53亿元。该股当日开盘25.98元,最高26.09元,最低25.86元,成交额达2249.58万元,换手率为0.21%。近日,成大生物发布关于2025年第二次临时股东会会议资料的公告。公司还拟续聘致同会计师事务所为2025年度审计机构,预计审计费用合计不超过70万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400041644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2592985841","title":"成大生物(688739)披露部分募投项目内部投资结构调整公告,12月19日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592985841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592985841?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:30","pubTimestamp":1766154656,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘,成大生物报收于26.24元,较前一交易日上涨0.34%,最新总市值为109.28亿元。该股当日开盘26.13元,最高26.35元,最低26.12元,成交额达3531.38万元,换手率为0.32%。近日,成大生物发布公告称,公司拟对部分募集资金投资项目进行内部投资结构调整。同时,公司还对生物技术产品研发生产基地项目的内部投资结构进行调整,增加土建投资,减少设备及净化工程投入,以提升项目建设质量。上述事项已通过董事会审议,尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000860.SH","688739"],"gpt_icon":0},{"id":"2592736132","title":"1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上","url":"https://stock-news.laohu8.com/highlight/detail?id=2592736132","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592736132?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:07","pubTimestamp":1766113620,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 公司快评 | 1个月终止6个研发子项目,成大生物应提升决策能力,确保资金用在“刀刃”上。 成大生物在一个月内密集终止6个研发子项目,这一行为在市场竞争加剧和业绩承压的背景下显得尤为突出。 成大生物2025年前三季度营收与归母净利润双双下滑,实现营收10.96亿元,同比降幅15.88%;归母净利润1.65亿元,同比大幅下降50.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-19/doc-inhcicem5855654.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-19/doc-inhcicem5855654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2592904738","title":"成大生物(688739)披露关于2025年第二次临时股东会增加临时提案暨延期召开的公告,12月18日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904738","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592904738?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:28","pubTimestamp":1766068080,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,成大生物报收于26.15元,较前一交易日上涨0.38%,最新总市值为108.9亿元。近日,辽宁成大生物股份有限公司发布公告称,因控股股东辽宁成大提请增加临时提案《关于部分募集资金投资项目内部投资结构调整的议案》,公司决定将2025年第二次临时股东会召开时间由原定的2025年12月23日延期至2025年12月31日,股权登记日仍为2025年12月16日。网络投票将于会议当日通过上交所系统进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800038915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2592970434","title":"成大生物最新公告:调整部分募集资金投资项目内部投资结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2592970434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592970434?lang=zh_cn&edition=full","pubTime":"2025-12-18 19:31","pubTimestamp":1766057465,"startTime":"0","endTime":"0","summary":"成大生物(688739.SH)公告称,公司拟对部分募集资金投资项目的内部投资结构进行调整,包括终止“人用疫苗研发项目”下的b型流感嗜血杆菌结合疫苗(hib疫苗)子项目,以及优化调整“生物技术产品研发生产基地项目”的内部投资结构。此次调整不涉及投资总额、实施主体及实施地点的变更,旨在优化募集资金使用效率。相关议案已通过董事会审议,尚需提交股东会审议。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800031637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2589870507","title":"成大生物:拟续聘致同会计师事务所为2025年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870507","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870507?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:38","pubTimestamp":1765111080,"startTime":"0","endTime":"0","summary":"证券日报网讯12月5日晚间,成大生物发布公告称,公司拟续聘致同会计师事务所(特殊普通合伙)为2025年度财务报告及内部控制审计机构,审计费用总额不超过70万元,其中财务审计费用55万元、内控审计费用15万元,与2024年度持平,该事项尚需12月23日股东会审议通过。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyxcz3133457.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyxcz3133457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688739"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770313483142,"stockEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0122},{"period":"3month","weight":-0.0561},{"period":"6month","weight":-0.0976},{"period":"1year","weight":0.0238},{"period":"ytd","weight":0.005}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.0019},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.2621},{"period":"ytd","weight":0.027}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辽宁成大生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24286人(较上一季度减少4.17%)","perCapita":"17147股","listingDate":"2021-10-28","address":"辽宁省沈阳市浑南区新放街1号","registeredCapital":"41645万元","survey":" 辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产与销售。公司的主要产品是人用狂犬病疫苗和人用乙脑灭活疫苗。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"成大生物,688739,成大生物股票,成大生物股票老虎,成大生物股票老虎国际,成大生物行情,成大生物股票行情,成大生物股价,成大生物股市,成大生物股票价格,成大生物股票交易,成大生物股票购买,成大生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}